Gertz, Morie http://orcid.org/0000-0002-3853-5196
Adams, David
Ando, Yukio
Beirão, João Melo
Bokhari, Sabahat
Coelho, Teresa
Comenzo, Raymond L.
Damy, Thibaud
Dorbala, Sharmila
Drachman, Brian M.
Fontana, Marianna
Gillmore, Julian D.
Grogan, Martha
Hawkins, Philip N.
Lousada, Isabelle
Kristen, Arnt V.
Ruberg, Frederick L.
Suhr, Ole B.
Maurer, Mathew S.
Nativi-Nicolau, Jose
Quarta, Candida Cristina
Rapezzi, Claudio
Witteles, Ronald
Merlini, Giampaolo
Funding for this research was provided by:
Amyloidosis Research Consortium
Article History
Received: 11 March 2020
Accepted: 25 August 2020
First Online: 23 September 2020
Ethics approval and consent to participate
: Not applicable since patient medical information was not directly included in this study. All data analyzed during this study were generated from cited published articles.
: Not applicable.
: MG reports personal fees from Ionis/Akcea, Alnylam, Prothena, Celgene, Janssen, Spectrum, Annexon, Appellis, Amgen, Medscape, Physicians Education Resource, AbbVie (Data Safety Monitoring board), Research to Practice; speaker fees from Teva, Johnson and Johnson, Medscape, DAVA Oncology; advisory boards for Pharmacyclics and Proclara; royalties from Springer Publishing; and grant funding from Amyloidosis Foundation, International Waldenstrom Foundation, Spectrum, and the National Cancer Institute (SPORE MM SPORE 5P50 CA186781–04).DA reports grants from Alnylam and Pfizer and personal fees from Prothena, GlaxoSmithKline, Alnylam, and Pfizer.YA, JMB, and PNH have nothing to disclose.SB reports personal fees from Pfizer.TC was paid per protocol for clinical trials from FoldRx, Pfizer, Ionis, and Alnylam and received grants from FoldRx and Pfizer; received support from Pfizer, Ionis, Biogen, and Alnylam to attend scientific meetings; and has presented on behalf of Pfizer, Alnylam, GlaxoSmithKline, Prothena, and Ionis/Akcea and received honoraria.RLC reports consulting fees from Prothena, Janssen, Amgen, Takeda, Sanofi-Aventis, Unum, Caelum and reports grant/research support from Prothena, Janssen, Takeda, and Karyopharm.TD reports grants from Pfizer and Alnylam Pharmaceuticals and reports personal fees from Ionis Pharmaceuticals, Prothena Group, and GlaxoSmithKline.SD reports personal fees from Pfizer, GE Healthcare, and Advanced Accelerator Applications.BMD reports personal fees from Pfizer and Alnylam Pharmaceuticals.MF reports a grant from GlaxoSmithKline and reports personal fees from British Heart Foundation, Pfizer, Alnylam Pharmaceuticals, and Prothena.JDG participated in advisory boards for Alnylam Pharmaceuticals and GlaxoSmithKline.MG reports grants from Eidos Therapeutics, Pfizer, Alnylam Pharmaceuticals, and Prothena.IL has received honoraria from Akcea Therapeutics.AVK reports personal fees from Akcea Therapeutics, Eidos Therapeutics, Pfizer, Alnylam Pharmaceuticals.FLR reports grants from Pfizer and personal fees from Pfizer and Alnylam Pharmaceuticals.OBS received honoraria and travel and consultancy fees from Ionis/Akcea, Alnylam, Prothena, and Intellia.MSM reports grants from Pfizer and Alnylam Pharmaceuticals and reports personal fees from Akcea Therapeutics, Ionis Pharmaceuticals, Prothena Corp, Pfizer, Alnylam Pharmaceuticals, Eidos Therapeutics, and GlaxoSmithKline.JNN reports grants from Pfizer, Eidos Therapeutics, and Akcea Therapeutics and personal fees from Pfizer, Akcea Therapeutics, Alnylam Pharmaceuticals, and Ionis Pharmaceuticals.CCQ reports personal fees from Alnylam Pharmaceuticals.CR reports grants from Pfizer and personal fees from Pfizer and Alnylam Pharmaceuticals.RW reports grants from Pfizer and Eidos Therapeutics and reports personal fees from Alnylam Pharmaceuticals, Pfizer, and Eidos Therapeutics.GM has received honoraria from Janssen and Prothena; travel support from Prothena and Celgene; and consulting fees from Millennium, Pfizer, Janssen, Prothena, and Ionis.